Siddharth Dave

Dr. Siddharth Dave

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2023 in British Journal of Anaesthesia
Verified
Journal Article
Closed access
KKKunal Karamchandani
Kunal Karamchandani
SDSiddharth Dave
Siddharth Dave
UHUlrike Hoffmann
Ulrike Hoffmann
AKAshish K Khanna
Ashish K Khanna
BSBernd Saugel
Bernd Saugel

1 October 2020 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Open access
PDF file
SCSreekanth Cheruku
Sreekanth Cheruku
SDSiddharth Dave
Siddharth Dave
KGKristina Goff
Kristina Goff
CPCaroline Park
Caroline Park
CECallie Ebeling
Callie Ebeling
CKCorey Kershaw
Corey Kershaw
Cardiopulmonary resuscitation (CPR) in patients with severe acute respiratory syndrome coronavirus-2–associated disease (coronavirus disease 2019) poses a unique challenge to health- care providers due to the risk of viral aerosolization and disease transmission. This has caused some centers to modify existing CPR procedures, limit the duration of CPR, or consider avoiding CPR altogether. In this review, the authors propose a procedure for CPR in the intensive care unit that minimizes the number of personnel in the immediate vicinity of the patient and conserves the use of scarce personal protective equipment. Highlighting the low likelihood of successful resuscitation in high-risk patients may prompt patients to decline CPR. The authors recommend the preemptive placement of central venous lines in high-risk patients with intravenous tubing extensions that allow for medication delivery from outside the patients’ rooms. During CPR, this practice can be used to deliver critical medications without delay. The use of a mechanical compression system for CPR further reduces the risk of infectious exposure to health- care providers. Extracorporeal membrane oxygenation should be reserved for patients with few comorbidities and a single failing organ system. Reliable teleconferencing tools are essential to facilitate communication between providers inside and outside the patients' rooms. General principles regarding the ethics and peri-resuscitative management of coronavirus 2019 patients also are discussed.

18 September 2020 in A&A Practice
Verified
Journal Article
Closed access
SDSiddharth Dave
Siddharth Dave
JTJennifer T. Thibodeau
Jennifer T. Thibodeau
KSKim Styrvoky
Kim Styrvoky
SBShyam H. Bhatt
Shyam H. Bhatt
Coronavirus disease 2019 (COVID-19) has a high incidence of cardiac involvement, commonly described as a new-onset cardiomyopathy. In this report, we describe a patient with a new manifestation of cardiac involvement in the setting of a COVID-19 diagnosis: that of takotsubo cardiomyopathy.

10 December 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
DDDana Darwish
Dana Darwish
PKPooja Kumar
Pooja Kumar
KUKhushi Urs
Khushi Urs
SDSiddharth Dave
Siddharth Dave
The development of inhaled anesthetics (IAs) has a rich history dating back many centuries. In modern times they have played a pivotal role in anesthesia and critical care by allowing deep sedation during periods of critical illness and surgery. In addition to their sedating effects, they have many systemic effects allowing for therapy beyond surgical anesthesia. In this narrative review we chronicle the evolution of IAs, from early volatile agents such as ether to the contemporary use of halogenated hydrocarbons. This is followed by a discussion of the mechanisms of action of these agents which primarily involve the modulation of lipid membrane properties and ion channel activity. IAs’ systemic effects are also examined, including their effects on the cardiovascular, respiratory, hepatic, renal and nervous systems. We discuss of the role of IAs in treating systemic disease processes including ischemic stroke, delayed cerebral ischemia, status epilepticus, status asthmaticus, myocardial ischemia, and intensive care sedation. We conclude with a review of the practical and logistical challenges of utilizing IAs outside the operating room as well as directions for future research. This review highlights the expanding clinical utility of IAs and their evolving role in the management of a diverse range of disease processes, offering new avenues for therapeutic exploration beyond anesthesia.

18 June 2025 in Cells
Verified
Journal Article
Open access
PDF file
DDDana Darwish
Dana Darwish
PKPooja Kumar
Pooja Kumar
KUKhushi Urs
Khushi Urs
SDSiddharth Dave
Siddharth Dave
Type 2 diabetes mellitus affects nearly 7% of the world’s population and is a significant contributor to the development of cardiovascular disease and heart failure. Historically, the pharmacologic therapy of cardiovascular disease has centered around blood pressure control, insulin and cholesterol management, the inhibition of the renin–angiotensin system, and catecholamine blockade. Recent evidence suggests that sodium–glucose cotransporter 2 (SGLT-2) inhibitors provide significant cardiovascular protection to patients with and without diabetes. The use of SGLT-2 inhibitors is associated with significant changes to serum biomarkers of cardiac function. In this narrative review, we summarize how biomarkers reflect physiologic aspects of cardiovascular function and how these are affected by the use of SGLT-2 inhibitors.

13 August 2025 in Journal of PeriAnesthesia Nursing
Verified
Journal Article
Closed access
SDSiddharth Dave
Siddharth Dave
CRChahat Rana
Chahat Rana
JMJade L. Marshall
Jade L. Marshall
BRBryan T. Romito
Bryan T. Romito
RRRanier G. Reyes
Ranier G. Reyes
JRJia W. Romito
Jia W. Romito